drugset / Trial / NCT05119920

Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease

NCT05119920

Phase 2 Completed 226 enrolled Glaukos Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Signs and Symptoms of Dry Eye Disease.

Timeline

Start
2022-01-03
Primary completion
2022-07-27
Completion
2022-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown Topical

Indications